Renal Cancer - Results from #3180

Real-world Clinical Outcomes of Pazopanib Immediately After Discontinuation of Immunotherapy for Advanced Renal Cell Carcinoma. November 18, 2019

PRISM protocol: a randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic renal cell carcinoma. November 18, 2019

The Microbiome in Benign Renal Tissue and in Renal Cell Carcinoma. November 15, 2019

Mining TCGA database for screening and identification of hub genes in kidney renal clear cell carcinoma microenvironment. November 15, 2019

Long-term Risk of Recurrence in Surgically Treated Renal Cell Carcinoma: A Post Hoc Analysis of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network E2805 Trial Cohort. November 15, 2019

Impact of the Type of Analgesic Therapy on Postsurgical Complications of Patients with Kidney Cancer Undergoing Nephrectomy. November 14, 2019

Health-related quality of life in localized renal masses: A matter of sparing nephrons or minimizing the incision? November 14, 2019

NCCN Guidelines Insights: Kidney Cancer, Version 2.2020. November 14, 2019

UK multicentre prospective evaluation of the Leibovich score in localised renal cell carcinoma: performance has altered over time. November 13, 2019

The Impact of Antibiotics on Prognosis of Metastatic Renal Cell Carcinoma in Japanese Patients Treated With Immune Checkpoint Inhibitors. November 13, 2019

Activation and function of receptor tyrosine kinases in human clear cell renal cell carcinomas. November 13, 2019

Surgical treatment of kidney tumor on a patient with second case of staghorn calculus and associated renal hydronephrosis: case report. November 12, 2019

Prognostic value of PD-L1 expression for surgically treated localized renal cell carcinoma: implications for risk stratification and adjuvant therapies. November 12, 2019

The miR-200 family as prognostic markers in clear cell renal cell carcinoma. November 12, 2019

Complete Remission of Bone Metastases in Renal Cell Carcinoma with Nivolumab. November 11, 2019

Identifying hub genes of clear cell renal cell carcinoma associated with the proportion of regulatory T cells by weighted gene co-expression network analysis. November 11, 2019

ACR Appropriateness Criteria® Post-Treatment Follow-up and Active Surveillance of Clinically Localized Renal Cell Cancer. November 11, 2019

MicroRNA-200 family expression analysis in metastatic clear cell renal cell carcinoma patients. November 8, 2019

Treatment Outcome of metastatic lesions from renal cell carcinoma underGoing Extra-cranial stereotactic body radioTHERapy: The together retrospective study. November 8, 2019

Phase I study of the mTOR inhibitor everolimus in combination with the histone deacetylase inhibitor panobinostat in patients with advanced clear cell renal cell carcinoma. November 8, 2019

Page 160 of 456